A Nice Outsourcing View
What is the current state of pharma contract development and manufacturing?
According to That’s Nice, the health of the contract development and manufacturing market correlates directly with the health of the overall pharma industry – and the good news is that both sectors are fairing well. For CDMOs, however, competition in the marketplace is strong, and many sponsors (52 percent) are looking to decrease their outsourcing spend over the next five years.
Here, we present a snapshot of the outsourcing sector based on the 2017 Nice Insight Contract Development and Manufacturing Report (1). The report is based on a survey of over 700 pharma industry professionals.
- Nice Insight, Contract Development and Manufacturing Report (2017). Available to purchase at www.pharmasalmanac.com/industry-reports.
Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.
